Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Quanterix CorpQTRX · Entity 6649 | SVP R&D and CTO | March 23, 2022 | March 28, 2022 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Quanterix Corp
Report date March 23, 2022 · Filed March 28, 2022
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 54,730 |
Reported balance
After 2022-03-23 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2022-03-23 · Sale · Disposed 3,266 · Balance 54,730 F1: The sale of shares reported on this Form 4 was made pursuant to a Rule 10b5-1 trading plan adopted on November 16, 2021. F2: Includes 7,287 restricted stock units. |
Filing footnotes · ownership attribution and instrument terms
F1: The sale of shares reported on this Form 4 was made pursuant to a Rule 10b5-1 trading plan adopted on November 16, 2021.
F2: Includes 7,287 restricted stock units.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 23, 2022 Filed Mar 28, 2022 21:02 UTC | Quanterix Corp QTRX · Entity 6649 | SaleCommon Stock | 3,266 | $30.00 | $97,980.00 |
DisclosureSEC source: 0001562180-22-002952 · primarydocument.xml · nonDerivative · entry 1 Duffy David C. · CIK 0001724566 · SVP R&D and CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 54,730 F1 · shares: The sale of shares reported on this Form 4 was made pursuant to a Rule 10b5-1 trading plan adopted on November 16, 2021. F2 · balance_after: Includes 7,287 restricted stock units. Read SEC document |
| February 04, 2022 Filed Feb 4, 2022 21:01 UTC | Quanterix Corp QTRX · Entity 6649 | SaleCommon Stock | 3,266 | $30.91 | $100,952.06 |
DisclosureSEC source: 0001562180-22-001138 · primarydocument.xml · nonDerivative · entry 1 Duffy David C. · CIK 0001724566 · SVP R&D and CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 57,996 F1 · shares: The sale of shares reported on this Form 4 was made pursuant to a Rule 10b5-1 trading plan adopted on November 16, 2021. F2 · balance_after: Includes 7,287 restricted stock units. Read SEC document |
| January 31, 2022 Filed Jan 31, 2022 21:12 UTC | Quanterix Corp QTRX · Entity 6649 | SaleCommon Stock | 3,266 | $30.00 | $97,980.00 |
DisclosureSEC source: 0001562180-22-000795 · primarydocument.xml · nonDerivative · entry 1 Duffy David C. · CIK 0001724566 · SVP R&D and CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 61,262 F1 · shares: The sale of shares reported on this Form 4 was made pursuant to a Rule 10b5-1 trading plan adopted on November 16, 2021. F2 · balance_after: Includes 7,653 restricted stock units. Read SEC document |
| January 03, 2022 Filed Jan 5, 2022 21:04 UTC | Quanterix Corp QTRX · Entity 6649 | Exercise / conversionStock Option (Right to buy) · Derivative | 21,023 | $0.00 Strike: $2.28 | $0.00 |
DisclosureSEC source: 0001562180-22-000222 · primarydocument.xml · derivative · entry 6 Duffy David C. · CIK 0001724566 · SVP R&D and CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 21,023 shares Expires 2022-02-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: All shares underlying this option have vested. Read SEC document |
| January 03, 2022 Filed Jan 5, 2022 21:04 UTC | Quanterix Corp QTRX · Entity 6649 | Exercise / conversionStock Option (right to buy) · Derivative | 15,556 | $0.00 Strike: $2.89 | $0.00 |
DisclosureSEC source: 0001562180-22-000222 · primarydocument.xml · derivative · entry 5 Duffy David C. · CIK 0001724566 · SVP R&D and CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 15,556 shares Expires 2023-05-21 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: All shares underlying this option have vested. Read SEC document |
| January 03, 2022 Filed Jan 5, 2022 21:04 UTC | Quanterix Corp QTRX · Entity 6649 | Exercise / conversionStock Option (right to buy) · Derivative | 4,667 | $0.00 Strike: $2.96 | $0.00 |
DisclosureSEC source: 0001562180-22-000222 · primarydocument.xml · derivative · entry 4 Duffy David C. · CIK 0001724566 · SVP R&D and CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 4,667 shares Expires 2024-07-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: All shares underlying this option have vested. Read SEC document |
| January 03, 2022 Filed Jan 5, 2022 21:04 UTC | Quanterix Corp QTRX · Entity 6649 | Exercise / conversionCommon Stock | 21,023 | $2.28 | $47,932.44 |
DisclosureSEC source: 0001562180-22-000222 · primarydocument.xml · nonDerivative · entry 3 Duffy David C. · CIK 0001724566 · SVP R&D and CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 64,528 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes 7,653 restricted stock units. Read SEC document |
| January 03, 2022 Filed Jan 5, 2022 21:04 UTC | Quanterix Corp QTRX · Entity 6649 | Exercise / conversionCommon Stock | 15,556 | $2.89 | $44,956.84 |
DisclosureSEC source: 0001562180-22-000222 · primarydocument.xml · nonDerivative · entry 2 Duffy David C. · CIK 0001724566 · SVP R&D and CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,505 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 03, 2022 Filed Jan 5, 2022 21:04 UTC | Quanterix Corp QTRX · Entity 6649 | Exercise / conversionCommon Stock | 4,667 | $2.96 | $13,814.32 |
DisclosureSEC source: 0001562180-22-000222 · primarydocument.xml · nonDerivative · entry 1 Duffy David C. · CIK 0001724566 · SVP R&D and CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,949 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 29, 2021 Filed Dec 30, 2021 21:57 UTC | Quanterix Corp QTRX · Entity 6649 | SaleCommon Stock | 1,667 | $40.71 | $67,863.57 |
DisclosureSEC source: 0001562180-21-007919 · primarydocument.xml · nonDerivative · entry 1 Duffy David C. · CIK 0001724566 · SVP R&D and CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,282 F1 · shares: The sale of shares reported on this Form 4 was made pursuant to a Rule 10b5-1 trading plan adopted on March 8, 2021. F2 · balance_after: Includes 8,019 restricted stock units. Read SEC document |
| November 19, 2021 Filed Nov 22, 2021 23:18 UTC | Quanterix Corp QTRX · Entity 6649 | SaleCommon Stock | 1,667 | $45.54 | $75,915.18 |
DisclosureSEC source: 0001562180-21-007206 · primarydocument.xml · nonDerivative · entry 1 Duffy David C. · CIK 0001724566 · SVP R&D and CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,949 F1 · shares: The sale of shares reported on this Form 4 was made pursuant to a Rule 10b5-1 trading plan adopted on March 8, 2021. F2 · balance_after: Includes 9,117 restricted stock units. Read SEC document |
| October 15, 2021 Filed Oct 19, 2021 20:00 UTC | Quanterix Corp QTRX · Entity 6649 | SaleCommon Stock | 1,667 | $51.47 | $85,800.49 |
DisclosureSEC source: 0001562180-21-006543 · primarydocument.xml · nonDerivative · entry 1 Duffy David C. · CIK 0001724566 · SVP R&D and CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,616 F1 · shares: The sale of shares reported on this Form 4 was made pursuant to a Rule 10b5-1 trading plan adopted on March 8, 2021. F2 · balance_after: Includes 9,117 restricted stock units. Read SEC document |
| September 22, 2021 Filed Oct 4, 2021 20:09 UTC | Quanterix Corp QTRX · Entity 6649 | SaleCommon Stock | 1,667 | $47.72 | $79,549.24 |
DisclosureSEC source: 0001562180-21-006231 · primarydocument.xml · nonDerivative · entry 1 Duffy David C. · CIK 0001724566 · SVP R&D and CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,283 F1 · shares: The sale of shares reported on this Form 4 was made pursuant to a Rule 10b5-1 trading plan adopted on March 8, 2021. F2 · balance_after: Includes 9,117 restricted stock units. Read SEC document |
| August 20, 2021 Filed Aug 20, 2021 20:08 UTC | Quanterix Corp QTRX · Entity 6649 | SaleCommon Stock | 1,667 | $46.13 | $76,898.71 |
DisclosureSEC source: 0001562180-21-005490 · primarydocument.xml · nonDerivative · entry 1 Duffy David C. · CIK 0001724566 · SVP R&D and CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,950 F1 · shares: The sale of shares reported on this Form 4 was made pursuant to a Rule 10b5-1 trading plan adopted on March 8, 2021. F2 · balance_after: Includes 9,483 restricted stock units. Read SEC document |
| July 14, 2021 Filed Jul 14, 2021 21:08 UTC | Quanterix Corp QTRX · Entity 6649 | SaleCommon Stock | 1,667 | $57.77 | $96,302.59 |
DisclosureSEC source: 0001562180-21-004938 · primarydocument.xml · nonDerivative · entry 1 Duffy David C. · CIK 0001724566 · SVP R&D and CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,617 F1 · shares: The sale of shares reported on this Form 4 was made pursuant to a Rule 10b5-1 trading plan adopted on March 8, 2021. F2 · balance_after: Includes 9,849 restricted stock units. Read SEC document |
| June 23, 2021 Filed Jun 23, 2021 21:27 UTC | Quanterix Corp QTRX · Entity 6649 | SaleCommon Stock | 1,667 | $62.11 | $103,537.37 |
DisclosureSEC source: 0001562180-21-004450 · primarydocument.xml · nonDerivative · entry 1 Duffy David C. · CIK 0001724566 · SVP R&D and CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,284 F1 · shares: The sale of shares reported on this Form 4 was made pursuant to a Rule 10b5-1 trading plan adopted on March 8, 2021. F2 · balance_after: Includes 10,215 restricted stock units. Read SEC document |
| May 28, 2021 Filed Jun 2, 2021 20:09 UTC | Quanterix Corp QTRX · Entity 6649 | SaleCommon Stock | 1,667 | $51.00 | $85,017.00 |
DisclosureSEC source: 0001562180-21-003918 · primarydocument.xml · nonDerivative · entry 1 Duffy David C. · CIK 0001724566 · SVP R&D and CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,951 F1 · shares: The sale of shares reported on this Form 4 was made pursuant to a Rule 10b5-1 trading plan adopted on March 8, 2021. F2 · balance_after: Includes 10,581 restricted stock units. Read SEC document |
| April 15, 2021 Filed Apr 15, 2021 20:59 UTC | Quanterix Corp QTRX · Entity 6649 | SaleCommon Stock | 1,667 | $62.14 | $103,587.38 |
DisclosureSEC source: 0001562180-21-002823 · primarydocument.xml · nonDerivative · entry 1 Duffy David C. · CIK 0001724566 · SVP R&D and CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,618 F1 · shares: The sale of shares reported on this Form 4 was made pursuant to a Rule 10b5-1 trading plan adopted on May 15, 2020. F2 · balance_after: Includes 10,947 restricted stock units. Read SEC document |
| March 19, 2021 Filed Mar 19, 2021 20:03 UTC | Quanterix Corp QTRX · Entity 6649 | SaleCommon Stock | 1,667 | $58.36 | $97,286.12 |
DisclosureSEC source: 0001562180-21-002370 · primarydocument.xml · nonDerivative · entry 1 Duffy David C. · CIK 0001724566 · SVP R&D and CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,285 F1 · shares: The sale of shares reported on this Form 4 was made pursuant to a Rule 10b5-1 trading plan adopted on May 15, 2020. F2 · balance_after: Includes 11,313 restricted stock units. Read SEC document |
| February 11, 2021 Filed Feb 12, 2021 21:00 UTC | Quanterix Corp QTRX · Entity 6649 | SaleCommon Stock | 1,667 | $79.62 | $132,726.54 |
DisclosureSEC source: 0001562180-21-001122 · primarydocument.xml · nonDerivative · entry 1 Duffy David C. · CIK 0001724566 · SVP R&D and CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,952 F1 · shares: The sale of shares reported on this Form 4 was made pursuant to a Rule 10b5-1 trading plan adopted on May 15, 2020. F2 · balance_after: Includes 13,304 restricted stock units. Read SEC document |
| February 08, 2021 Filed Feb 10, 2021 21:10 UTC | Quanterix Corp QTRX · Entity 6649 | GrantStock Option (right to buy) · Derivative | 5,008 | $0.00 Strike: $77.79 | $0.00 |
DisclosureSEC source: 0001562180-21-001037 · primarydocument.xml · derivative · entry 2 Duffy David C. · CIK 0001724566 · SVP R&D and CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,008 Underlying: Common Stock · 5,008 shares Expires 2031-02-08 F3 · derivative.exercise_date: The option vests as to 25% of the shares on February 8, 2022, and the remaining 75% vests in 36 equal monthly installments at the end of each month beginning on February 28, 2022. Read SEC document |
| February 08, 2021 Filed Feb 10, 2021 21:10 UTC | Quanterix Corp QTRX · Entity 6649 | GrantCommon Stock | 2,146 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-21-001037 · primarydocument.xml · nonDerivative · entry 1 Duffy David C. · CIK 0001724566 · SVP R&D and CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,619 F1 · shares: Represents shares of stock issuable on vesting of restricted stock units. The restricted stock units vest as to 25% of the shares on February 8, 2022, and the remaining 75% vest in 36 equal monthly installments at the end of each month beginning on February 28, 2022. F2 · balance_after: Includes 13,304 restricted stock units. Read SEC document |
| January 22, 2021 Filed Jan 22, 2021 23:47 UTC | Quanterix Corp QTRX · Entity 6649 | SaleCommon Stock | 1,667 | $79.29 | $132,176.43 |
DisclosureSEC source: 0001562180-21-000487 · primarydocument.xml · nonDerivative · entry 1 Duffy David C. · CIK 0001724566 · SVP R&D and CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,473 F1 · shares: The sale of shares reported on this Form 4 was made pursuant to a Rule 10b5-1 trading plan adopted on May 15, 2020. F2 · balance_after: Includes 11,389 restricted stock units. Read SEC document |
| December 18, 2020 Filed Dec 21, 2020 22:03 UTC | Quanterix Corp QTRX · Entity 6649 | Exercise / conversionStock Option (Right to buy) · Derivative | 1,630 | $0.00 Strike: $2.28 | $0.00 |
DisclosureSEC source: 0001562180-20-007392 · primarydocument.xml · derivative · entry 3 Duffy David C. · CIK 0001724566 · SVP R&D and CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,023 Underlying: Common Stock · 1,630 shares Expires 2022-02-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Option is fully vested. Read SEC document |
| December 18, 2020 Filed Dec 21, 2020 22:03 UTC | Quanterix Corp QTRX · Entity 6649 | SaleCommon Stock | 1,667 | $43.82 | $73,047.94 |
DisclosureSEC source: 0001562180-20-007392 · primarydocument.xml · nonDerivative · entry 2 Duffy David C. · CIK 0001724566 · SVP R&D and CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,140 F1 · shares: The sale of shares reported on this Form 4 was made pursuant to a Rule 10b5-1 trading plan adopted on May 15, 2020. F2 · balance_after: Includes 11,620 restricted stock units. Read SEC document |
| December 18, 2020 Filed Dec 21, 2020 22:03 UTC | Quanterix Corp QTRX · Entity 6649 | Exercise / conversionCommon Stock | 1,630 | $2.28 | $3,716.40 |
DisclosureSEC source: 0001562180-20-007392 · primarydocument.xml · nonDerivative · entry 1 Duffy David C. · CIK 0001724566 · SVP R&D and CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,807 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 12, 2020 Filed Nov 16, 2020 21:51 UTC | Quanterix Corp QTRX · Entity 6649 | SaleCommon Stock | 1,667 | $49.39 | $82,333.13 |
DisclosureSEC source: 0001562180-20-006714 · primarydocument.xml · nonDerivative · entry 1 Duffy David C. · CIK 0001724566 · SVP R&D and CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,177 F1 · shares: The sale of shares reported on this Form 4 was made pursuant to a Rule 10b5-1 trading plan adopted on May 15, 2020. F2 · balance_after: Includes 11,851 restricted stock units. Read SEC document |
| October 16, 2020 Filed Oct 20, 2020 20:15 UTC | Quanterix Corp QTRX · Entity 6649 | SaleCommon Stock | 1,667 | $43.04 | $71,747.68 |
DisclosureSEC source: 0001562180-20-006391 · primarydocument.xml · nonDerivative · entry 1 Duffy David C. · CIK 0001724566 · SVP R&D and CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,844 F1 · shares: The sale of shares reported on this Form 4 was made pursuant to a Rule 10b5-1 trading plan adopted on May 15, 2020. F2 · balance_after: Includes 12,082 restricted stock units. Read SEC document |
| September 17, 2020 Filed Sep 17, 2020 21:47 UTC | Quanterix Corp QTRX · Entity 6649 | SaleCommon Stock | 1,667 | $32.43 | $54,060.81 |
DisclosureSEC source: 0001562180-20-006034 · primarydocument.xml · nonDerivative · entry 1 Duffy David C. · CIK 0001724566 · SVP R&D and CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,511 F1 · shares: The sale of shares reported on this Form 4 was made pursuant to a Rule 10b5-1 trading plan adopted on May 15, 2020. F2 · balance_after: Includes 12,313 restricted stock units. Read SEC document |
| August 19, 2020 Filed Aug 20, 2020 20:32 UTC | Quanterix Corp QTRX · Entity 6649 | SaleCommon Stock | 1,680 | $34.92 | $58,665.60 |
DisclosureSEC source: 0001562180-20-005581 · primarydocument.xml · nonDerivative · entry 1 Duffy David C. · CIK 0001724566 · SVP R&D and CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,178 F1 · shares: The sale of shares reported on this Form 4 was made pursuant to a Rule 10b5-1 trading plan adopted on December 3, 2019. F2 · balance_after: Includes 12,544 restricted stock units. Read SEC document |
| July 13, 2020 Filed Jul 14, 2020 21:49 UTC | Quanterix Corp QTRX · Entity 6649 | SaleCommon Stock | 1,667 | $27.39 | $45,659.13 |
DisclosureSEC source: 0001562180-20-005113 · primarydocument.xml · nonDerivative · entry 1 Duffy David C. · CIK 0001724566 · SVP R&D and CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,858 F1 · shares: The sale of shares reported on this Form 4 was made pursuant to a Rule 10b5-1 trading plan adopted on December 3, 2019. F2 · balance_after: Includes 12,775 restricted stock units. Read SEC document |
| June 16, 2020 Filed Jun 18, 2020 20:58 UTC | Quanterix Corp QTRX · Entity 6649 | SaleCommon Stock | 1,667 | $26.35 | $43,925.45 |
DisclosureSEC source: 0001562180-20-004580 · primarydocument.xml · nonDerivative · entry 1 Duffy David C. · CIK 0001724566 · SVP R&D and CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,525 F1 · shares: The sale of shares reported on this Form 4 was made pursuant to a Rule 10b5-1 trading plan adopted on December 3, 2019. F2 · balance_after: Includes 13,006 restricted stock units. Read SEC document |
| May 08, 2020 Filed May 12, 2020 22:21 UTC | Quanterix Corp QTRX · Entity 6649 | SaleCommon Stock | 1,667 | $26.52 | $44,208.84 |
DisclosureSEC source: 0001562180-20-003548 · primarydocument.xml · nonDerivative · entry 1 Duffy David C. · CIK 0001724566 · SVP R&D and CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,192 F1 · shares: The sale of shares reported on this Form 4 was made pursuant to a Rule 10b5-1 trading plan adopted on December 3, 2019. F2 · balance_after: Includes 13,237 restricted stock units. Read SEC document |
| April 15, 2020 Filed Apr 17, 2020 20:08 UTC | Quanterix Corp QTRX · Entity 6649 | SaleCommon Stock | 1,667 | $20.87 | $34,790.29 |
DisclosureSEC source: 0001562180-20-003038 · primarydocument.xml · nonDerivative · entry 1 Duffy David C. · CIK 0001724566 · SVP R&D and CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,859 F1 · shares: The sale of shares reported on this Form 4 was made pursuant to a Rule 10b5-1 trading plan adopted on December 3, 2019. F2 · balance_after: Includes 13,468 restricted stock units. Read SEC document |
| March 19, 2020 Filed Mar 20, 2020 21:03 UTC | Quanterix Corp QTRX · Entity 6649 | SaleCommon Stock | 1,667 | $11.46 | $19,103.82 |
DisclosureSEC source: 0001562180-20-002653 · primarydocument.xml · nonDerivative · entry 1 Duffy David C. · CIK 0001724566 · SVP R&D and CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 54,526 F1 · shares: The sale of shares reported on this Form 4 was made pursuant to a Rule 10b5-1 trading plan adopted on December 3, 2019. F2 · balance_after: Includes 13,699 restricted stock units. Read SEC document |
| February 18, 2020 Filed Feb 21, 2020 01:18 UTC | Quanterix Corp QTRX · Entity 6649 | GrantStock Option (right to buy) · Derivative | 15,167 | $0.00 Strike: $27.76 | $0.00 |
DisclosureSEC source: 0001562180-20-001434 · primarydocument.xml · derivative · entry 2 Duffy David C. · CIK 0001724566 · SVP R&D and CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,167 Underlying: Common Stock · 15,167 shares Expires 2030-02-18 F3 · derivative.exercise_date: The option vests as to 25% of the shares on February 18, 2021 and vests as to an additional 2.083% of the shares per month for 36 months thereafter. Read SEC document |
| February 18, 2020 Filed Feb 21, 2020 01:18 UTC | Quanterix Corp QTRX · Entity 6649 | GrantCommon Stock | 6,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-20-001434 · primarydocument.xml · nonDerivative · entry 1 Duffy David C. · CIK 0001724566 · SVP R&D and CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 56,193 F1 · shares: Represents shares of stock issuable on vesting of restricted stock units. The restricted stock units vest as to 25% of the shares on February 18, 2021 and vest as to an additional 2.083% of the shares per month for 36 months thereafter. F2 · balance_after: Includes 14,771 restricted stock units. Read SEC document |
| February 11, 2020 Filed Feb 11, 2020 21:50 UTC | Quanterix Corp QTRX · Entity 6649 | SaleCommon Stock | 1,667 | $27.88 | $46,475.96 |
DisclosureSEC source: 0001562180-20-001085 · primarydocument.xml · nonDerivative · entry 1 Duffy David C. · CIK 0001724566 · SVP R&D and CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,693 F1 · shares: The sale of shares reported on this Form 4 was made pursuant to a Rule 10b5-1 trading plan adopted on December 3, 2019. F2 · balance_after: Includes 8,721 restricted stock units. Read SEC document |
| January 17, 2020 Filed Jan 18, 2020 01:46 UTC | Quanterix Corp QTRX · Entity 6649 | Exercise / conversionStock Option (Right to buy) · Derivative | 1,941 | $0.00 Strike: $1.93 | $0.00 |
DisclosureSEC source: 0001562180-20-000434 · primarydocument.xml · derivative · entry 3 Duffy David C. · CIK 0001724566 · SVP R&D and CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,941 shares Expires 2021-07-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: Option is fully vested. Read SEC document |
| January 17, 2020 Filed Jan 18, 2020 01:46 UTC | Quanterix Corp QTRX · Entity 6649 | SaleCommon Stock | 1,941 | $23.99 | $46,564.59 |
DisclosureSEC source: 0001562180-20-000434 · primarydocument.xml · nonDerivative · entry 2 Duffy David C. · CIK 0001724566 · SVP R&D and CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,360 F2 · shares: The sale of shares reported on this Form 4 was made pursuant to a Rule 10b5-1 trading plan adopted on December 3, 2019. F3 · price: This transaction was executed in multiple trades at prices ranging from $23.95 to $24.03. The price reported reflects the weighted average sale price. The reporting person undertakes to provide upon request to the SEC staff, the issuer or any security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F1 · balance_after: Includes 8,835 restricted stock units. Read SEC document |
| January 17, 2020 Filed Jan 18, 2020 01:46 UTC | Quanterix Corp QTRX · Entity 6649 | Exercise / conversionCommon Stock | 1,941 | $1.93 | $3,746.13 |
DisclosureSEC source: 0001562180-20-000434 · primarydocument.xml · nonDerivative · entry 1 Duffy David C. · CIK 0001724566 · SVP R&D and CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 53,301 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes 8,835 restricted stock units. Read SEC document |
| December 18, 2019 Filed Dec 20, 2019 23:40 UTC | Quanterix Corp QTRX · Entity 6649 | Exercise / conversionStock Option (Right to buy) · Derivative | 6,600 | $0.00 Strike: $2.28 | $0.00 |
DisclosureSEC source: 0001562180-19-006222 · primarydocument.xml · derivative · entry 2 Duffy David C. · CIK 0001724566 · SVP R&D and CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,513 Underlying: Common Stock · 6,600 shares Expires 2022-02-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Option is fully vested. Read SEC document |
| December 18, 2019 Filed Dec 20, 2019 23:40 UTC | Quanterix Corp QTRX · Entity 6649 | Exercise / conversionCommon Stock | 6,600 | $2.28 | $15,048.00 |
DisclosureSEC source: 0001562180-19-006222 · primarydocument.xml · nonDerivative · entry 1 Duffy David C. · CIK 0001724566 · SVP R&D and CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,360 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes 8,949 restricted stock units. Read SEC document |
| December 16, 2019 Filed Dec 16, 2019 21:17 UTC | Quanterix Corp QTRX · Entity 6649 | Exercise / conversionStock Option (Right to Buy) · Derivative | 1,667 | $0.00 Strike: $1.93 | $0.00 |
DisclosureSEC source: 0001562180-19-006094 · primarydocument.xml · derivative · entry 3 Duffy David C. · CIK 0001724566 · SVP R&D and CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,941 Underlying: Common Stock · 1,667 shares Expires 2021-07-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Option is fully vested. Read SEC document |
| December 16, 2019 Filed Dec 16, 2019 21:17 UTC | Quanterix Corp QTRX · Entity 6649 | SaleCommon Stock | 1,667 | $24.15 | $40,258.05 |
DisclosureSEC source: 0001562180-19-006094 · primarydocument.xml · nonDerivative · entry 2 Duffy David C. · CIK 0001724566 · SVP R&D and CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,760 F1 · shares: The sale of shares reported on this Form 4 was made pursuant to a Rule 10b5-1 trading plan adopted on May 16, 2019. F2 · balance_after: Includes 8,949 restricted stock units. Read SEC document |
| December 16, 2019 Filed Dec 16, 2019 21:17 UTC | Quanterix Corp QTRX · Entity 6649 | Exercise / conversionCommon Stock | 1,667 | $1.93 | $3,217.31 |
DisclosureSEC source: 0001562180-19-006094 · primarydocument.xml · nonDerivative · entry 1 Duffy David C. · CIK 0001724566 · SVP R&D and CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,427 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 18, 2019 Filed Nov 19, 2019 23:18 UTC | Quanterix Corp QTRX · Entity 6649 | Exercise / conversionStock Option (Right to Buy) · Derivative | 1,667 | $0.00 Strike: $1.93 | $0.00 |
DisclosureSEC source: 0001562180-19-005590 · primarydocument.xml · derivative · entry 3 Duffy David C. · CIK 0001724566 · SVP R&D and CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,608 Underlying: Common Stock · 1,667 shares Expires 2021-07-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: Option is fully vested. Read SEC document |
| November 18, 2019 Filed Nov 19, 2019 23:18 UTC | Quanterix Corp QTRX · Entity 6649 | SaleCommon Stock | 1,667 | $22.56 | $37,614.69 |
DisclosureSEC source: 0001562180-19-005590 · primarydocument.xml · nonDerivative · entry 2 Duffy David C. · CIK 0001724566 · SVP R&D and CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,760 F1 · shares: The sale of shares reported on this Form 4 was made pursuant to a Rule 10b5-1 trading plan adopted on May 16, 2019. F2 · price: This transaction was executed in multiple trades at prices ranging from $22.53 to $22.58. The price reported reflects the weighted average sale price. The reporting person undertakes to provide upon request to the SEC staff, the issuer or any security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F3 · balance_after: Includes 9,063 restricted stock units. Read SEC document |
| November 18, 2019 Filed Nov 19, 2019 23:18 UTC | Quanterix Corp QTRX · Entity 6649 | Exercise / conversionCommon Stock | 1,667 | $1.93 | $3,217.31 |
DisclosureSEC source: 0001562180-19-005590 · primarydocument.xml · nonDerivative · entry 1 Duffy David C. · CIK 0001724566 · SVP R&D and CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,427 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 21, 2019 Filed Oct 21, 2019 21:22 UTC | Quanterix Corp QTRX · Entity 6649 | Exercise / conversionStock Option (Right to Buy) · Derivative | 1,667 | $0.00 Strike: $1.93 | $0.00 |
DisclosureSEC source: 0001562180-19-005204 · primarydocument.xml · derivative · entry 3 Duffy David C. · CIK 0001724566 · SVP R&D and CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,275 Underlying: Common Stock · 1,667 shares Expires 2021-07-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: Option is fully vested. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.